200 related articles for article (PubMed ID: 8904134)
1. Once-a-day therapy of cefpodoxime proxetil for respiratory tract infections.
Sawae Y; Ninomiya K; Sumida I; Inoue T; Takaki K; Okada K; Kumagai Y; Ishimaru T; Shimono N; Misumi H
J Chemother; 1995 Nov; 7 Suppl 4():134-6. PubMed ID: 8904134
[No Abstract] [Full Text] [Related]
2. Clinical evaluation of cefpodoxime proxetil in patients with dermatological infections.
Imaizumi T; Ishikawa H; Hashimoto I
J Chemother; 1995 Nov; 7 Suppl 4():137-41. PubMed ID: 8904135
[No Abstract] [Full Text] [Related]
3. [Clinical evaluation of cefpodoxime proxetil on the treatment of bacterial infections].
Li JT; Hou J; Kao L
Zhonghua Nei Ke Za Zhi; 1994 Jul; 33(7):440-3. PubMed ID: 7867436
[TBL] [Abstract][Full Text] [Related]
4. Cefpodoxime proxetil: dosage, efficacy and tolerance in adults suffering from respiratory tract infections.
Safran C
J Antimicrob Chemother; 1990 Dec; 26 Suppl E():93-101. PubMed ID: 2292535
[TBL] [Abstract][Full Text] [Related]
5. Evaluation of cefpodoxime proxetil dry syrup in pediatric patients with various infections.
Muranaka H; Yokoyama M
J Chemother; 1995 Nov; 7 Suppl 4():127-30. PubMed ID: 8904132
[No Abstract] [Full Text] [Related]
6. [Bacterial infections of the respiratory tract and of the ENT area. Cephalosporin in general practice is effective].
Hanke K; Blum SP
MMW Fortschr Med; 2002 Mar; 144(13):36. PubMed ID: 12001587
[No Abstract] [Full Text] [Related]
7. A multi-institutional study on clinical effectiveness of cefpodoxime proxetil dry syrup in childhood infections.
Imanaka H; Kitahara T; Yoshinaga M; Miyata K
J Chemother; 1995 Nov; 7 Suppl 4():131-3. PubMed ID: 8904133
[No Abstract] [Full Text] [Related]
8. Comparison of oral cefpodoxime proxetil and cefaclor in the treatment of skin and soft tissue infections.
Stevens DL; Pien F; Drehobl M
Diagn Microbiol Infect Dis; 1993 Feb; 16(2):123-9. PubMed ID: 8467623
[TBL] [Abstract][Full Text] [Related]
9. Bioavailability of cefpodoxime proxetil with co-administered acetylcysteine.
Kees F; Wellenhofer M; Bröhl K; Grobecker H
Arzneimittelforschung; 1996 Apr; 46(4):435-8. PubMed ID: 8740095
[TBL] [Abstract][Full Text] [Related]
10. Microbiological and clinical studies on cefpodoxime proxetil for bacterial skin and soft tissue infections in pediatric patients.
Ito K; Ito M
J Chemother; 1995 Nov; 7 Suppl 4():124-6. PubMed ID: 8904131
[No Abstract] [Full Text] [Related]
11. Clinical evaluation of cefpodoxime proxetil dry syrup in pediatric cutaneous bacterial infection.
Terui T; Tagami H
J Chemother; 1995 Nov; 7 Suppl 4():119-21. PubMed ID: 8904129
[No Abstract] [Full Text] [Related]
12. Cefpodoxime proxetil. An appraisal of its use in antibacterial cost-containment programmes, as stepdown and abbreviated therapy in respiratory tract infections.
Balfour JA; Benfield P
Pharmacoeconomics; 1996 Aug; 10(2):164-78. PubMed ID: 10163419
[TBL] [Abstract][Full Text] [Related]
13. [Comparative trial of the clinical efficacy and tolerance of cefatrizine (Cefaperos) and cefpodoxime proxetil (Orelox) in superinfections of chronic obstructive bronchopneumopathies in adults in urban practice].
Brambilla C; Benhamou D; Guérin JC; Kelkel E; Muir JF; Prud'homme A; Taytard A; Fauche A
Pathol Biol (Paris); 1995 Nov; 43(9):815-24. PubMed ID: 8746104
[TBL] [Abstract][Full Text] [Related]
14. [Clinical evaluation of cefpodoxime in respiratory tract infections].
Fukuhara H; Irabu Y; Kakazu T; Nakamura H; Shigeno Y; Saito A; Owan T; Oshiro H; Miyaguni T; Nakasone K
Jpn J Antibiot; 1993 Jan; 46(1):53-9. PubMed ID: 8455331
[TBL] [Abstract][Full Text] [Related]
15. [Clinical studies of cefpodoxime proxetil in respiratory tract infections].
Odagiri S; Matsunaga K; Suzuki K; Murohashi K; Takahashi H; Numata H; Takahashi K; Yamaki I; Ishii S
Jpn J Antibiot; 1988 Oct; 41(10):1538-44. PubMed ID: 3204658
[TBL] [Abstract][Full Text] [Related]
16. Comparison of once daily cefpodoxime proxetil suspension and thrice daily cefaclor suspension in the treatment of acute otitis media in children.
Tsai HY; Huang LM; Chiu HH; Hsueh PR; Lee PI; Lu CY; Chiu TF; Lin HC; Lee CY
J Microbiol Immunol Infect; 1998 Sep; 31(3):165-70. PubMed ID: 10496153
[TBL] [Abstract][Full Text] [Related]
17. [Respiratory tract infections in general practice. Cefpodoxime proxetil in patients with risk factors and concomitant illnesses].
Kardos P; Wiese K
MMW Fortschr Med; 2000 Feb; 142(5):41. PubMed ID: 10715939
[No Abstract] [Full Text] [Related]
18. [Treatment of infectious complications affecting the skin and soft tissues with cefpodoxime proxetil].
Vyhnánek F; Lochmann O
Epidemiol Mikrobiol Imunol; 1996 May; 45(2):68-70. PubMed ID: 8756403
[TBL] [Abstract][Full Text] [Related]
19. Cefpodoxime proxetil.
Del Beccaro MA
Pediatr Ann; 1993 Mar; 22(3):187-92, 195-6. PubMed ID: 8464650
[No Abstract] [Full Text] [Related]
20. Efficacy and tolerance of cefpodoxime proxetil compared with ceftriaxone in vulnerable patients with bronchopneumonia.
Zuck P; Rio Y; Ichou F
J Antimicrob Chemother; 1990 Dec; 26 Suppl E():71-7. PubMed ID: 2292534
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
